Advertisement
Advertisement
TXG
10x Genomics, Inc. Class A Common Stock
18.60
USDSponsored
+0.90
+5.07%
Feb 06, 15:59 UTC -5
Closed
After-Market
18.62
+0.02
+0.12%
TXG Earnings Reports
Positive Surprise Ratio
TXG beat 13 of 25 last estimates.
52%
Next Report
Next Week
Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$160.22M
/-$0.21
Implied change from Q3 25 (Revenue/ EPS)
+7.53%
/-4.55%
Implied change from Q4 24 (Revenue/ EPS)
-2.91%
/-47.50%
10x Genomics, Inc. Class A Common Stock earnings per share and revenue
On Nov 06, 2025, TXG reported earnings of -0.22 USD per share (EPS) for Q3 25, beating the estimate of -0.29 USD, resulting in a 24.40% surprise. Revenue reached 149.00 million, compared to an expected 143.91 million, with a 3.54% difference. The market reacted with a +17.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 160.22 million USD, implying an decrease of -4.55% EPS, and increase of 7.53% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Doximity, Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$0.45
Actual
$0.46
Surprise
+1.21%
Omnicell Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.50
Actual
$0.40
Surprise
-20.98%
Azenta, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$0.14
Actual
$0.09
Surprise
-35.94%
FAQ
What were 10x Genomics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.22, beating estimates by 24.4%, and revenue of $149.00M, 3.54% above expectations.
How did the market react to 10x Genomics, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 17.31%, changed from $13.00 before the earnings release to $15.25 the day after.
When is 10x Genomics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for 10x Genomics, Inc. Class A Common Stock's next earnings report?
Based on 18
analysts, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.21 and revenue of $160.22M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement